 
			
			
	
			CASI Pharmaceuticals Files CTA (IND) for Novel Multiple Myeloma Treatment
According to a recent press release, biopharmaceutical company CASI Pharmaceuticals filed a Clinical Trial Application (CTA) (IND) in the United Kingdom. CASI Pharmaceuticals is hoping to test the safety…
 
								 
								 
			
			
	 
			
			
	 
			
			
	 
			
			
	 
			
			
	 
			
			
	 
			
			
	 
			
			
	 
			
			
	 
			
			
	 
			
			
	 
			
			
	 
			
			
	 
			
			
	 
			
			
	 
			
			
	 
			
			
	 
			
			
	 
			
			
	 
			
			
	 
			
			
	 
			
			
	 
			
			
	 
															 
            